An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes

The ability to produce unlimited numbers of human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs) harboring disease and patient-specific gene variants creates a new paradigm for modeling congenital heart diseases (CHDs) and predicting proarrhythmic liabilities of drug candidates. Ho...

Descripció completa

Dades bibliogràfiques

Autors principals:	Wesley L. McKeithan, Alex Savchenko, Michael S. Yu, Fabio Cerignoli, Arne A. N. Bruyneel, Jeffery H. Price, Alexandre R. Colas, Evan W. Miller, John R. Cashman, Mark Mercola
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2017-10-01
Col·lecció:	Frontiers in Physiology
Matèries:	induced pluripotent stem cells cardiomyocyte voltage sensitive probe high throughput screening drug development cardiotoxicity
Accés en línia:	http://journal.frontiersin.org/article/10.3389/fphys.2017.00766/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!